ARTICLE | Clinical News
Aerucin regulatory update
August 3, 2015 7:00 AM UTC
FDA granted Fast Track designation to Aridis’ Aerucin to treat hospital-acquired and ventilator-associated pneumonia caused by Pseudomonas aeruginosa. The human IgG1 mAb against P. aeruginosa is in P...